Detalhe da pesquisa
1.
Phase I/II study evaluating the safety and clinical efficacy of temsirolimus and bevacizumab in patients with chemotherapy refractory metastatic castration-resistant prostate cancer.
Invest New Drugs;
37(2): 331-337, 2019 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30402678
2.
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.
N Engl J Med;
373(8): 737-46, 2015 Aug 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26244877
3.
Ketoconazole plus Lenalidomide in patients with Castration-Resistant Prostate Cancer (CRPC): results of an open-label phase II study.
Invest New Drugs;
36(6): 1085-1092, 2018 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30191523
4.
A phase 2 study of OSI-906 (linsitinib, an insulin-like growth factor receptor-1 inhibitor) in patients with asymptomatic or mildly symptomatic (non-opioid requiring) metastatic castrate resistant prostate cancer (CRPC).
Invest New Drugs;
36(3): 451-457, 2018 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29476383
5.
Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial.
Lancet;
388(10043): 488-97, 2016 Jul 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27291997
6.
Incidence of hypercoagulable events after image-guided percutaneous cryoablation of renal tumors: a single-center experience.
J Vasc Interv Radiol;
25(5): 776-9, 2014 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24656177
7.
Clinicopathological characteristics and treatment outcomes of oesophageal cancer patients in Uganda.
Ecancermedicalscience;
17: 1576, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37533943
8.
Exploring Barriers to Pediatric Cancer Clinical Trials: The Role of a Networked, Just-in-Time Study Program.
Clin Ther;
45(11): 1148-1150, 2023 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37783645
9.
Operational Metrics for the ELAINE 2 Study Combining a Traditional Approach With a Just-in-TIME Model.
JCO Clin Cancer Inform;
7: e2200164, 2023 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37352479
10.
A phase II study of tandutinib (MLN518), a selective inhibitor of type III tyrosine receptor kinases, in patients with metastatic renal cell carcinoma.
Invest New Drugs;
30(1): 364-7, 2012 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20711630
11.
A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors.
Invest New Drugs;
29(1): 126-30, 2011 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19774342
12.
Characteristics and outcomes of patients with multiple myeloma at the Uganda Cancer Institute.
Afr Health Sci;
21(1): 67-74, 2021 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34394283
13.
Forensic isoscapes based on intra-individual temporal variation of δ 18O and 206Pb/207Pb in human teeth.
Forensic Sci Res;
6(1): 42-52, 2020 Aug 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34007515
14.
Phase I trial of docetaxel given every 3 weeks and daily lenalidomide in patients with advanced solid tumors.
Invest New Drugs;
27(5): 453-60, 2009 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19011760
15.
Relationships between expression of BCS1L, mitochondrial bioenergetics, and fatigue among patients with prostate cancer.
Cancer Manag Res;
11: 6703-6717, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31410061
16.
Phase I/II trial of 5-fluorouracil and a noncytotoxic dose level of suramin in patients with metastatic renal cell carcinoma.
Clin Genitourin Cancer;
6(2): 79-85, 2008 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18824429
17.
Insights into Geographic and Temporal Variation in Fatty Acid Composition of Croton Nuts Using ATR-FTIR.
Int J Anal Chem;
2018: 4739759, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30254676
18.
Evaluating the impact of the genitourinary multidisciplinary tumour board: Should every cancer patient be discussed as standard of care?
Can Urol Assoc J;
12(9): E403-E408, 2018 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29787374
19.
Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel.
J Clin Oncol;
36(4): 376-382, 2018 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29261442
20.
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial.
J Clin Oncol;
36(11): 1080-1087, 2018 04 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29384722